<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04387097</url>
  </required_header>
  <id_info>
    <org_study_id>TSGHIRB No: 2-108-05-135</org_study_id>
    <nct_id>NCT04387097</nct_id>
  </id_info>
  <brief_title>Drip-infusion of Remifentanil for RIH</brief_title>
  <official_title>Postoperative Drip-infusion of Remifentanil for Preventing Remifentanil-induced Hyperalgesia- a Retrospective Observative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tri-Service General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tri-Service General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The development of remifentanil-induced hyperalgesia (RIH) is an unpleasant experience for
      surgical patients. An alternative management, gradual withdrawal of remifentanil was
      effective in prevention of RIH. The investigators designed a simple modality to assess if
      under withdrawal of remifentanil and further drip-infusion of remifentanil immediately after
      extubation affected postoperative pain score, the requirement of rescue analgesics, and
      adverse effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In clinical practice, the gradual withdrawal of remifentanil during surgery is unsatisfied.
      Thus, the investigators conducted a simple modality in a single center retrospective cohort
      study to assess how under baseline gradual withdrawal of remifentanil and further drip
      infusion of remifentanil immediately after extubation affected postoperative pain score and
      use of analgesics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">July 22, 2019</completion_date>
  <primary_completion_date type="Actual">January 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>comparison of the numeric rating scale (NRS) between 2 groups</measure>
    <time_frame>one hour</time_frame>
    <description>NRS scores is labeled from zero to ten, with zero being an example of someone with no pain and ten being the worst pain possible.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>requirement for rescue analgesics</measure>
    <time_frame>one hour</time_frame>
    <description>postoperative requirement for rescue analgesics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>type of surgery</measure>
    <time_frame>three hours</time_frame>
    <description>type of surgery in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>surgical site</measure>
    <time_frame>three hours</time_frame>
    <description>surgical site in both groups</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">559</enrollment>
  <condition>Hyperalgesia</condition>
  <arm_group>
    <arm_group_label>gradual withdrawal following by drip-infusion of remifentanil</arm_group_label>
    <description>In the end of the surgery, gradual withdrawal of remifentanil was prescribed until the endotracheal tube was extubated. Following by drip-infusion of remifentanil for 30 minutes was administered immediately after tracheal extubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gradual withdrawal of remifentanil</arm_group_label>
    <description>In the end of the surgery, gradual withdrawal of remifentanil was prescribed until the endotracheal tube was extubated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil</intervention_name>
    <description>postoperative drip-infusion of remifentanil</description>
    <arm_group_label>gradual withdrawal following by drip-infusion of remifentanil</arm_group_label>
    <other_name>drip-infusion</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients receiving surgery with age between 20-80 years
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) score of I-III patients receiving total
             intravenous anesthesia

        Exclusion Criteria:

          -  The use of inhalation agents or propofol combined with inhalation anesthesia

          -  Pregnancy

          -  Previous substance abuse

          -  Known allergies to opioids, propofol or any drugs used in the study

          -  History of neuropsychiatric disorder

          -  Age &lt; 20 years or &gt; 80 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi-hsuan Huang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tri-Service General Hospital and National Defense Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>TriService General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11490</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <results_reference>
    <citation>Comelon M, Raeder J, Stubhaug A, Nielsen CS, Draegni T, Lenz H. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia. Br J Anaesth. 2016 Apr;116(4):524-30. doi: 10.1093/bja/aev547. Epub 2016 Mar 1.</citation>
    <PMID>26934941</PMID>
  </results_reference>
  <results_reference>
    <citation>Saxena S, Gonsette K, Terram W, Huybrechts I, Nahrwold DA, Cappello M, Barvais L, Engelman E. Gradual withdrawal of remifentanil delays initial post-operative analgesic demand after thyroid surgery; double-blinded, randomized controlled trial. BMC Anesthesiol. 2019 Apr 25;19(1):60. doi: 10.1186/s12871-019-0731-9.</citation>
    <PMID>31027480</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 8, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2020</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tri-Service General Hospital</investigator_affiliation>
    <investigator_full_name>Yi-hsuan Huang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Remifentanil</keyword>
  <keyword>Hyperalgesia</keyword>
  <keyword>Drip-infusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is not a plan to make IPD available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

